Skip to main content

Table 2 A summary of effect size for tocolytic treatment versus placebo for extremely preterm birth outcomes in RCTs

From: Tocolysis for inhibiting preterm birth in extremely preterm birth, multiple gestations and in growth-restricted fetuses: a systematic review and meta-analysis

Tocolysis compared to placebo in women with extremely preterm birth (RCTs)

Patient or population: Women with extremely preterm birth

Intervention: Tocolysis (atosiban and ritodrine)

Comparison: Placebo

Outcomes

Anticipated absolute effectsf (95 % CI)

Relative effect (95 % CI)

№ of participants (studies)

Quality of the evidence (GRADE)

Risk with placebo

Risk with tocolysis

Prolongation of pregnancy >24 h

Study population

RR 1.15 (0.81 to 1.63)

77 (1 RCT)

MODERATE a

59 per 100

68 per 100 (476 to 959)

Prolongation of pregnancy >48 h

Study population

RR 1.40 (0.83 to 1.31)

117 (2 RCTs)

VERY LOW a,b

69 per 100

96 per 100 (57 to 90)

Prolongation of pregnancy >7 days

Study population

RR 1.05 (0.75 to 1.48)

117 (2 RCTs)

VERY LOW a,b

65 per 100

68 per 100 (49 to 96)

Perinatal death

Study population

RR 2.22 (0.26 to 19.24)

265 (2 RCTs)

VERY LOW c,d,e

17 per 100

37 per 100 (4 to 100)

GRADE Working Group grades of evidence

High quality: We are very confident that the true effect lies close to that of the estimate of the effect

Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different

Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect

Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aTotal number of cases less than 300

bAllocation concealment not performed

cOne study with unclear randomization and one study without allocation concealment

dLarge heterogeneity (>60 %)

eSmall sample size (<300) and wide confidence interval

  1. CI Confidence interval; RR Risk ratio; OR Odds ratio
  2. fThe risk in the intervention group (and its 95 % confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95 % CI)